Dr. Wetmore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Pediatric Hospital Medicine
Duluth, MN 55805
Summary
- Dr. Cynthia Wetmore is a pediatric hospitalist and is affiliated with St. Luke's Hospital in Duluth, MN. She received her medical degree from University of Minnesota Medical School and has been in practice 22 years. In addition to the practice of hospital medicine, she specializes in pediatric hematology-oncology and is experienced in pediatric neuro-oncology, clincial trials, quality improvement and translational research.
Clinical Expertise
- Oncology, Pediatric neuro-oncology, Clincial trials, Translational Research
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Pediatrics, 2001 - 2002
- University of TennesseeFellowship, Pediatric Hematology/Oncology, 1997 - 2001
- University of MinnesotaResidency, Pediatrics, 1995 - 1997
- University of Minnesota Medical SchoolClass of 1995
- Karolinska InstitutetPhD, Histology and Neurobiology, 1992
- Harvard UniversityB.A., History of Science, Magna Cum Laude, 1986
Certifications & Licensure
- AZ State Medical License 2017 - 2026
- CA State Medical License 2021 - 2025
- MN State Medical License 2001 - 2025
- MS State Medical License 2022 - 2024
- GA State Medical License 2014 - 2020
- TN State Medical License 2010 - 2014
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Award for basic/translational science International Society for Pediatric Oncology (SIOP), 2007
- Distinguished Scientist Award Sontag Foundation, 2004
- Award for Excellence in Teaching Mayo College of Medicine, 2003
- Join now to see all
Clinical Trials
- PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma Start of enrollment: 2011 Jul 01
- A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors Start of enrollment: 2015 Dec 11
- Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors Start of enrollment: 2016 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsFeasibility and Efficacy of a Computer-Based Intervention Aimed at Preventing Reading Decoding Deficits Among Children Undergoing Active Treatment for Medulloblastoma:...Shawna L. Palmer, Laurie Leigh, Susan C. Ellison, Arzu Onar-Thomas, Shengjie Wu
Journal of Pediatric Psychology. 2014-05-01 - 44 citationsAPOBEC3B-mediated Corruption of the Tumor Cell Immunopeptidome Induces Heteroclitic Neoepitopes for Cancer ImmunotherapyChristopher B. Driscoll, Matthew Schuelke, Timothy Kottke, Jill Thompson, Phonphimon Wongthida
Nature Communications. 2020-02-07 - 17 citationsA phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from th...Thomas Cash, Elizabeth Fox, Xiaowei Liu, Charles G. Minard, Joel M. Reid
Pediatric Blood & Cancer. 2021-04-21
Journal Articles
- Phase I trial, pharmacokinetics and pharmacodynamics of vandetanib and dasatanib in children with newly diagnosed diffuse intrinsic pontine gliomaBroniscer A, Baker SD, Wetmore C, Pai-Panandiker A, Huang J, Davidoff AM, Onar-Thomas A, Panetta JC, Chin TK, Merchant TE, Baker JN, Kaste SC, Gajjar A, Stewart CF, Clin Cancer Res, 1/27/2013
- Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS)Roberts MS, Turner DC, Owens TS, Ramachandran A, Wetmore C, Throm SL, Stewart CF, J Chromatogr B Analyt Technol Biomed Life Sci, 1/15/2013
- Diffuse leptomemingeal gliomatosisJicha GA, Glantz J, Clarke MJ, Lehwald LM Russo DP, Giannini C, Wald JT, Uhm J, Kumar N, Aksamit AJ, Wetmore CJ, Eur Neurol, 1/1/2009
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- First in Pediatrics Phase I study of crenolanib (CP-868,596) administered during and after radiation therapy (RT) in newly-diagnosed diffuse intrinsic pontine glioma (...Wetmore, C., Broniscer, A., Wright, K., Armstrong, G., Baker, J., Kun, L., Patay, Z., Onar-Thomas, A., Ramachandran, A., Turner, D., Gajjar, A., Stewart, C, ASCO Annual Meeting, Chicago, IL, 1/1/2014
- Activity of alisertib (MLN8237) as single agent in recurrent atypical teratiod tumor (ATRT) in four children: a single patient treatment plan pilot study.Wetmore C, Bendel A, Gajjar A, Rhabdoid Tumors: Integrating biological insights with clinical successes. Institut Curie, Paris, France, 1/1/2013
- A Phase I trial of MK-0752 in Pediatric Patients with Recurrent or Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study.M. Fouladi, J. Olson, C.F. Stewart, M. Kocak, A. Onar-Thomas, L. Wagner, R. J. Packer, S. Goldman, S. Gururangan, S. M. Blaney, I. Pollack, C. Smith, A. Gajjar, T. Dem..., SNO Annual Meeting, 1/1/2013
- Join now to see all
Lectures
- Research 101: Tissue acquisition and Bio-banking.1/1/2014
- The Cancer Answer: Progress and PossibilitiesWoodruff Arts Center, Atlanta, GA - 1/1/2014
- PDGFR signaling in diffuse pontine glioma.Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY - 1/1/2013
- Join now to see all
Press Mentions
- Examining COVID’s Impact on Clinical Research Participant DiversityFebruary 21st, 2022
- Fertility Preservation for Pediatric and Adolescent Patients with Cancer: Medical and Ethical ConsiderationsMarch 2nd, 2020
- Gilbert Girl, 7, Takes on Battle for Her LifeSeptember 6th, 2019
- Join now to see all
Professional Memberships
- Member
- American Society of Pediatric Hematology/OncologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: